Concepedia

Ina Bühnen

IB

Statistics

Publications

4

Citations

133

H-Index

4

Active since

2021

Affiliations

University of Cologne(Current)

University Hospital Cologne

Düsseldorf University Hospital

Goethe University Frankfurt

University of Duisburg-Essen

Ina Bühnen is an author at University of Cologne specializing in oncology, medicine, and hematologic malignancy therapy.

Publications per year

2021–2023

4

Publications

4

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial

Paul J. Bröckelmann, Ina Bühnen, Karolin Trautmann‐Grill et al. · Journal of Clinical Oncology · 2022 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study

Dennis A. Eichenauer, Stefanie Kreissl, Ina Bühnen et al. · Annals of Oncology · 2021 · 20 citations · Full text

Medicine, Hematology, Oncology +11

Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies

Dennis A. Eichenauer, Ina Bühnen, Christian Baues et al. · Blood · 2023 · 11 citations · Full text

Medicine, Nuclear Medicine, Molecular Imaging +1

Low B‐cell content is associated with a <scp>CD73</scp>‐low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma

Johanna Grund, Katharina Iben, Sarah Reinke et al. · British Journal of Haematology · 2023 · 10 citations · Full text

Life Sciences, Immunology, Oncology +14

1–4 of 4